Book contents
- Mental Disorders Around the World
- Mental Disorders Around the World
- Copyright page
- Contents
- Acknowledgements
- Contributors
- Section I Introduction
- Section II The Disorders
- 4 Major Depressive Disorder
- 5 Bipolar Spectrum Disorder
- 6 Generalized Anxiety Disorder
- 7 Panic Disorder and Panic Attacks
- 8 Agoraphobia
- 9 Social Anxiety Disorder
- 10 Specific Phobia
- 11 Posttraumatic Stress Disorder
- 12 Separation Anxiety Disorder
- 13 Intermittent Explosive Disorder
- 14 Attention-Deficit Hyperactivity Disorder
- 15 Oppositional Defiant Disorder and Conduct Disorder
- 16 Alcohol-Use Disorders
- 17 Drug-Use Disorders
- 18 Bulimia Nervosa and Binge-Eating Disorder
- 19 Psychotic Experiences
- Section III Overview
- Appendices
- Index
- References
17 - Drug-Use Disorders
from Section II - The Disorders
Published online by Cambridge University Press: 28 December 2017
Book contents
- Mental Disorders Around the World
- Mental Disorders Around the World
- Copyright page
- Contents
- Acknowledgements
- Contributors
- Section I Introduction
- Section II The Disorders
- 4 Major Depressive Disorder
- 5 Bipolar Spectrum Disorder
- 6 Generalized Anxiety Disorder
- 7 Panic Disorder and Panic Attacks
- 8 Agoraphobia
- 9 Social Anxiety Disorder
- 10 Specific Phobia
- 11 Posttraumatic Stress Disorder
- 12 Separation Anxiety Disorder
- 13 Intermittent Explosive Disorder
- 14 Attention-Deficit Hyperactivity Disorder
- 15 Oppositional Defiant Disorder and Conduct Disorder
- 16 Alcohol-Use Disorders
- 17 Drug-Use Disorders
- 18 Bulimia Nervosa and Binge-Eating Disorder
- 19 Psychotic Experiences
- Section III Overview
- Appendices
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Mental Disorders Around the WorldFacts and Figures from the World Mental Health Surveys, pp. 243 - 262Publisher: Cambridge University PressPrint publication year: 2018
References
Alonso, J., Petukhova, M., Vilagut, G., et al. (2011). Days out of role due to common physical and mental conditions: results from the WHO World Mental Health surveys. Molecular Psychiatry 16, 1234–46.Google Scholar
American Psychiatric Association (2000). Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR). Washington, DC: American Psychiatric Association.Google Scholar
American Psychiatric Association (2014). Diagnostic and Statistical Manual of Mental Disorders (Fifth Edition). Washington, DC: American Psychiatric Association.Google Scholar
Babor, T. F. & Caetano, R. (2008). The trouble with alcohol abuse: what are we trying to measure, diagnose, count and prevent? Addiction 103, 1057–9.CrossRefGoogle ScholarPubMed
Batki, S. L. & Harris, D. S. (2004). Quantitative drug levels in stimulant psychosis: relationship to symptom severity, catecholamines and hyperkinesia. American Journal on Addictions 13, 461–70.CrossRefGoogle ScholarPubMed
Boles, S. M. & Miotto, K. (2003). Substance abuse and violence: a review of the literature. Aggression and Violent Behavior 8, 155–74.Google Scholar
Calabria, B., Degenhardt, L., Hall, W., et al. (2010). Does cannabis use increase the risk of death? Systematic review of epidemiological evidence on adverse effects of heavy cannabis use. Drug and Alcohol Review 29, 318–30.CrossRefGoogle Scholar
Cornish, J. W. & O'Brien, C. P. (1996). Crack cocaine abuse: an epidemic with many public health consequences. Annual Review of Public Health 17, 2559–273.Google Scholar
Cregler, L. L. (1989). Adverse health consequences of cocaine abuse. Journal of the National Medical Association 81, 27–38.Google Scholar
Degenhardt, L., Bucello, C., Calabria, B., et al. (2011a). What data are available on the extent of illicit drug use and dependence globally? Results of four systematic reviews. Drug & Alcohol Dependence 117, 85–101.Google Scholar
Degenhardt, L., Bucello, C., Mathers, B., et al. (2011b). Mortality among regular or dependent users of heroin and other opioids: a systematic review and meta-analysis of cohort studies. Addiction 106, 32–51.Google Scholar
Degenhardt, L., Charlson, F., Stanaway, J., et al. (2016a). Estimating the burden of disease attributable to injecting drug use as a risk factor for HIV, hepatitis C, and hepatitis B: findings from the Global Burden of Disease Study 2013. The Lancet Infectious Diseases 16, 1385–98.CrossRefGoogle ScholarPubMed
Degenhardt, L., Chiu, W., Sampson, N., et al. (2008). Toward a global view of alcohol, tobacco, cannabis, and cocaine use: findings from the WHO World Mental Health Surveys. PLoS Medicine 5, 1053–67.Google Scholar
Degenhardt, L. & Hall, W. (2012). Extent of illicit drug use and dependence, and their contribution to the global burden of disease. Lancet 379, 55–70.Google Scholar
Degenhardt, L., Hall, W. & Warner-Smith, M. (2006). Using cohort studies to estimate mortality among injecting drug users that is not attributable to AIDS. Sexually Transmitted Infections 82, 56–63.Google Scholar
Degenhardt, L., Hall, W. & Warner-Smith, M. et al. (2004). Illicit drug use. In Comparative Quantification of Health Risk: Global and Regional Burden of Disease Attribution to Selected Major Risk Factors (ed. Ezzati, M., Lopez, A. D., Rodgers, A., & Murray, C. J. L.). Geneva: World Health Organization.Google Scholar
Degenhardt, L., Hall, W. D., & Lynskey, M. (2001). The relationship between cannabis use, depression and anxiety among Australian adults: findings from the National Survey of Mental Health and Well-Being. Social Psychiatry and Psychiatric Epidemiology 36, 219–27.CrossRefGoogle ScholarPubMed
Degenhardt, L., Singleton, J., Calabria, B., et al. (2011c). Mortality among cocaine users: a systematic review of cohort studies. Drug & Alcohol Dependence 113, 88–95.Google Scholar
Degenhardt, L., Stockings, E., Patton, G., et al. (2016b). The increasing global health priority of substance use in young people. The Lancet Psychiatry 3, 251–64.Google Scholar
Degenhardt, L., Whiteford, H. A., Ferrari, A. J., et al. (2013). Global burden of disease attributable to illicit drug use and dependence: findings from the Global Burden of Disease Study 2010. Lancet 382, 1564–74.CrossRefGoogle ScholarPubMed
Falck, R. S., Wang, J., Siegal, H. A., & Carlson, R. G. (2003). Current physical health problems and their predictors among a community sample of crack-cocaine smokers in Ohio. Journal of Psychoactive Drugs 35, 471–78.CrossRefGoogle ScholarPubMed
Greater London Alcohol and Drug Alliance (2004). The GLADA Crack Cocaine Strategy 2005–08. London: Greater London Authority.Google Scholar
Hall, W. & Degenhardt, L. (2007). Prevalence and correlates of cannabis use in developed and developing countries. Current Opinion in Psychiatry 20, 393–97.CrossRefGoogle ScholarPubMed
Hall, W., Degenhardt, L., & Teesson, M. (2009). Understanding comorbidity between substance use, anxiety and affective disorders: broadening the research base. Addictive Behaviors 34, 526–30.Google ScholarPubMed
Lago, L., Bruno, R., & Degenhardt, L. (2016). Concordance of ICD-11 and DSM-5 definitions of alcohol and cannabis use disorders: a population survey. The Lancet Psychiatry 3, 673–84.Google Scholar
Lago, L., Glantz, M., Kessler, R. C., et al. (2017). Substance dependence among those without symptoms of substance abuse in the World Mental Health Survey. International Journal of Methods in Psychiatric Research e1557. DOI: 10.1002/mpr.1557.Google Scholar
Lai, H. M., Cleary, M., Sitharthan, T., et al. (2015). Prevalence of comorbid substance use, anxiety and mood disorders in epidemiological surveys, 1990–2014: a systematic review and meta-analysis. Drug & Alcohol Dependence 154, 1–13.Google Scholar
Larney, S., Peacock, A., Mathers, B. M., et al. (2017). A systematic review of injecting-related injury and disease among people who inject drugs. Drug & Alcohol Dependence 171, 39–49.Google Scholar
Marzuk, P. M., Tardiff, K., Leon, A. C., et al. (1992). Prevalence of cocaine use among residents of New York City who committed suicide during a one-year period. American Journal of Psychiatry 149, 371–5.Google ScholarPubMed
McKetin, R., McLaren, J., Riddell, S., et al. (2006). The relationship between methamphetamine use and violent behaviour. Crime and Justice Bulletin 97, 1–16.Google Scholar
Mooney, M., Sofuoglu, M., Dudish-Poulsen, S., & Hatsukami, D. K. (2006). Preliminary observations of paranoia in a human laboratory study of cocaine. Addictive Behaviors 31, 1245–54.Google Scholar
Pani, P. P., Maremmani, I., Trogu, E., et al. (2010). Delineating the psychic structure of substance abuse and addictions: should anxiety, mood and impulse-control dysregulation be included? Journal of Affective Disorders 122, 185–97.CrossRefGoogle Scholar
Rounsaville, B. J., Spitzer, R. L., & Williams, J. B. (1986). Proposed changes in DSM-III substance use disorders: description and rationale. American Journal of Psychiatry 143, 463–8.Google Scholar
Roy, A. (2001). Characteristics of cocaine-dependent patients who attempt suicide. American Journal of Psychiatry 158, 1215–19.Google Scholar
Satel, S. L., Southwick, S. M., & Gawin, F. H. (1991). Clinical features of cocaine-induced paranoia. American Journal of Psychiatry 148, 495–8.Google Scholar
Segal, D. S. & Kuczenski, R. (1997). Repeated binge exposures to amphetamine and methamphetamine: behavioral and neurochemical characterization[comment]. Journal of Pharmacology & Experimental Therapeutics 282, 561–73.Google Scholar
Sher, K., Wolf, S., & Martinez, J. (2009). How can etiological research inform the distinction between normal drinking and disordered drinking. In Handbook of Drug Use Etiology: Theory, Methods, and Empirical Findings (ed. Scheier, L. M.). Washington: American Psychological Association, 225–46.Google Scholar
Singleton, J., Degenhardt, L., Hall, W., et al. (2009). Mortality among amphetamine users: a systematic review of cohort studies. Drug & Alcohol Dependence 105, 1–8.Google Scholar
Slade, T., Chiu, W.-T., Glantz, M., et al. (2016). A cross-national examination of differences in classification of lifetime alcohol use disorder between DSM-IV and DSM-5: findings from the World Mental Health Survey. Alcoholism, Clinical and Experimental Research 40, 1728–36.Google Scholar
Srisurapanont, M., Ali, R., Marsden, J., et al. (2003). Psychotic symptoms in methamphetamine psychotic in-patients. International Journal of Neuropsychopharmacology 6, 347–52.Google Scholar
United Nations Office on Drugs and Crime (2008). 2008 Global ATS Assessment: Amphetamines and Ecstasy. Vienna: United Nations.Google Scholar
United Nations Office on Drugs and Crime (2009). World Drug Report 2009. Vienna: United Nations.Google Scholar
World Health Organization (2016). The Health and Social Effects of Nonmedical Cannabis Use. Geneva: World Health Organization.Google Scholar
Wright, S. & Klee, H. (2001). Violent Crime, aggression and amphetamine: what are the implications for drug treatment services? Drugs: Education, Prevention and Policy 8, 70–90.Google Scholar